KOA SHOJI HOLDINGS (9273) FY2026 Q2 Earnings Report

Quick View

Executive Summary

The first half was characterized by higher revenue and profits, but weak cash backing for earnings. Revenue was ¥126.5B (+3.2% year on year), Operating Income was ¥31.7B (+3.4%), Ordinary Income was ¥31.1B (+1.6%), and interim Net Income attributable to owners of the parent was ¥20.9B (+1.8%). While the Company maintained high profitability with an Operating Income margin of 25.0%, Operating Cash Flow (OCF) was limited to ¥3.6B, representing just 0.17x Net Income and indicating weak cash generation relative to earnings.

Factors Affecting Business Performance

【Revenue】Revenue was ¥126.5B, an increase of +3.2% year on year. By segment, DrugSubstanceSales (active pharmaceutical ingredient sales) generated ¥84.7B (67.0% of total), while PharmaceuticalMarketing generated ¥48.4B (38.2%), with both segments serving as sources of earnings. PharmaceuticalMarketing had a margin of 27.7%, exceeding DrugSubstanceSales’ 21.1%, making it the relatively more profitable business.

【Profit and Loss】Operating Income increased to ¥31.7B (+3.4%) in line with higher revenue, while the Operating Income margin remained high at 25.0%. Ordinary Income was limited to ¥31.1B (+1.6%), with the decline from Operating Income primarily attributable to non-operating expenses of ¥0.7B, mainly consisting of a foreign exchange loss of ¥0.6B. Net Income was ¥20.9B (+1.8%), securing an increase in profit even after recording income taxes and other taxes of ¥10.3B. Extraordinary gains and losses were immaterial, consisting of a gain on the sale of fixed assets of ¥0.03B, and the gap between Ordinary Income and Net Income was limited. In conclusion, both revenue and profit increased.

Segment Analysis

The segments comprise PharmaceuticalMarketing and DrugSubstanceSales. DrugSubstanceSales generated Revenue of ¥84.7B (67.0% of total), Operating Income of ¥17.8B, and a margin of 21.1%. PharmaceuticalMarketing generated Revenue of ¥48.4B (38.2% of total), Operating Income of ¥13.4B, and a relatively high margin of 27.7%. Total segment profit matches consolidated Operating Income, while the adjustment amount of ¥0.8B reflects the elimination of intersegment transactions and corporate expenses. Although active pharmaceutical ingredient sales are the primary source of revenue, the high margin of the marketing business provides support for overall profitability.

Key Financial Indicators

【Profitability】The Operating Income margin of 25.0% and Net Income margin of 16.5% were both high and remained broadly flat year on year (the Operating Income margin improved slightly, while the Net Income margin declined somewhat due to the impact of the foreign exchange loss). 【Cash Quality】Operating CF was ¥3.6B, representing a low 0.17x relative to Net Income of ¥20.85B, primarily due to a ¥21.9B increase in trade receivables. Receivables expanded at a pace exceeding the 3.2% increase in revenue, warranting attention to the speed of earnings conversion into cash. 【Investment Efficiency】ROE was 7.1% and the total asset turnover ratio was a relatively low 0.347x. The Company’s substantial capital base, reflected in an Equity Ratio of 80.9%, structurally constrains asset efficiency. Construction in progress of ¥33.2B accounted for 36.6% of property, plant and equipment, making the contribution of revenue and profit after the assets become operational a key factor in improving capital efficiency. 【Financial Soundness】The Equity Ratio was 80.9% (up from 77.9% in the previous year), while interest-bearing debt was limited to approximately ¥19.5B against cash and deposits of ¥131.6B, indicating an extremely sound financial position.

Cash Flow Analysis

Operating CF was ¥3.6B, a substantial decrease from ¥10.1B in the same period of the previous year. Investing CF was negative ¥12.9B, Financing CF was negative ¥8.3B, and Free Cash Flow was negative ¥9.3B. The decline in Operating CF was primarily due to a ¥21.9B increase in trade receivables and a ¥1.7B increase in inventories, partly offset by a ¥4.8B increase in trade payables. Investing CF was primarily related to the acquisition of property, plant and equipment of ¥13.0B, reflecting continued capital investment, including construction in progress. Financing CF was mainly attributable to repayment of long-term borrowings of ¥1.5B and dividend payments of ¥6.7B. Although Free Cash Flow was negative, the Company held cash and deposits of ¥131.6B, limiting the impact on short-term liquidity.

Quality of Earnings

The decline from Operating Income of ¥31.7B to Ordinary Income of ¥31.1B resulted from non-operating expenses of ¥0.7B, including a foreign exchange loss of ¥0.6B, while non-operating income was limited to ¥0.1B. Extraordinary gains and losses consisted only of a ¥0.03B gain on the sale of fixed assets, and the impact of one-time factors on current-period profit was immaterial. Comprehensive income was ¥21.0B, broadly in line with Net Income attributable to owners of the parent of ¥20.9B, with other comprehensive income items, including valuation differences on securities of ¥0.2B, being small. Meanwhile, the gap between Operating CF and Net Income was substantial, and the Operating CF/Net Income ratio of 0.17x indicates that the accounting profit for the period was not accompanied by sufficient cash collection. The working capital burden resulting from the increase in trade receivables is the most important point to monitor when assessing earnings quality.

Earnings Forecast and Guidance

The full-year Company plan calls for Revenue of ¥257.0B (+10.4% year on year), Operating Income of ¥54.3B (+1.4%), and Ordinary Income of ¥54.3B (+1.0%). Based on first-half results, progress rates were 49.2% for Revenue, 58.4% for Operating Income, and 57.3% for Ordinary Income. While progress on the profit side exceeded the standard first-half progress rate of 50%, achieving the Revenue plan will require approximately 18% year-on-year growth in the second half. The Operating Income margin required in the second half is calculated at approximately 17.3%, below the first-half margin of 25.0%, suggesting that the plan incorporates a change in the profit margin associated with revenue expansion.

Shareholder Returns

The dividend at the end of Q2 was ¥0 per share, while the full-year Company forecast is an annual dividend of ¥18.0 per share. Based on the period-average number of shares outstanding of 42,118,504 shares, total annual dividends are approximately ¥7.6B, and the forecast Payout Ratio against forecast full-year Net Income of ¥36.4B is approximately 20.8%, representing dividends only and excluding share repurchases. As first-half Free Cash Flow was negative ¥9.3B, dividends were not covered by first-half cash flow alone. However, given cash and deposits of ¥131.6B and low interest-bearing debt, the Company has sufficient payment capacity.

Risk Factors

1. Increase in trade receivables and collection cycle: Trade receivables increased by ¥21.9B, expanding at a pace exceeding the 3.2% growth in revenue. This was the primary cause of the low cash conversion ratio of 0.17x for Operating CF/Net Income, making trends in collections a key area of focus going forward.

2. Concentration of non-operational investment in construction in progress: Construction in progress was ¥33.2B, accounting for 36.6% of property, plant and equipment of ¥90.7B. The timing of commencement of operations and the status of investment recovery will affect improvements in asset turnover and Free Cash Flow.

3. Non-operating expenses due to foreign exchange losses: Non-operating expenses of ¥0.7B, including a foreign exchange loss of ¥0.6B, were recorded and restrained growth at the stage from Operating Income to Ordinary Income. Profit and loss fluctuations related to foreign-currency-denominated transactions may continue to affect Ordinary Income.

Industry Benchmark (Reference, Based on Our Analysis)

Industry Benchmark (trading)

Profitability and Returns

The Net Income margin significantly exceeds the industry median, and profitability is relatively high within the industry.

Growth and Capital Efficiency

Revenue growth was slightly below the industry median, and the pace of growth was within the standard range for the industry.

※Source: Based on our analysis

Key Points from the Earnings Results

1. The Operating Income margin of 25.0% and Net Income margin of 16.5% remained high, indicating solid earnings-generating capacity in the core business. Meanwhile, the Operating CF/Net Income ratio remained at 0.17x, with the gap between profit and cash being a defining feature of the first half.

2. Progress against the full-year plan exceeded standard levels on the profit side, with Operating Income at 58.4% and Ordinary Income at 57.3%, while Revenue was at 49.2%, requiring approximately 18% revenue growth in the second half.

3. Construction in progress of ¥33.2B accounted for 36.6% of property, plant and equipment, indicating that large-scale investment is under way. A structural feature is that investment is being conducted primarily using internal funds, supported by the substantial capital base represented by an Equity Ratio of 80.9%.

Theoretical Share Price (Reference Value)

Sensitivity: ¥742–¥787 at ±1% for the cost of equity, and ¥762–¥766 at ±0.1 for ω.

Notes:

• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by our company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q2 was a solid earnings period for コーア商事ホールディングス, with modest top-line growth and operating-profit growth broadly matching sales growth. Revenue increased 3.2% year on year to ¥12.65bn. Operating income rose 3.4% to ¥3.17bn. Net income increased 1.8% to ¥2.09bn, slower than operating income because non-operating expenses increased materially. Gross profit rose 4.8% to ¥4.36bn, exceeding revenue growth. The gross margin expanded by approximately 50bp year on year to 34.4%. SG&A expense increased 8.7% to ¥1.19bn, faster than revenue, but remained limited at 9.4% of sales. Consequently, the operating margin improved slightly by approximately 10bp to 25.0%, a very high level for the stated benchmarks. Ordinary income increased only 1.6% to ¥3.11bn, as foreign-exchange losses of ¥61m weighed on below-the-line earnings. The effective tax rate was 33.0%, producing a tax burden ratio of 0.669. The reported annualized ROE was 14.1%, supported principally by a 16.5% net margin and low financial leverage of 1.24x. Balance-sheet liquidity remains exceptionally strong, with cash and deposits of ¥13.16bn, a 494.5% current ratio, and debt/EBITDA of just 0.56x. However, cash conversion was weak: operating cash flow was only ¥0.36bn, equal to 0.17x net income and 0.10x EBITDA. The principal cash-flow drag was a ¥2.19bn increase in trade receivables, while inventories also increased by ¥0.17bn. Investment cash outflow of ¥1.29bn, mainly purchases of non-current assets, drove free cash flow to negative ¥0.93bn. Construction in progress reached ¥3.32bn, or 36.6% of PPE, indicating a substantial ongoing capital project that requires execution and return-on-investment monitoring. Q2 revenue reached 49.2% of full-year guidance and operating income reached 58.4%, versus the conventional 50% first-half progress level. The profit progress outperformance, alongside a full-year sales-growth plan of 10.4%, suggests guidance assumes a more weighted second-half sales contribution and/or margin moderation. The financial profile can absorb current investment and working-capital needs, but the near-term investment case will depend on receivable collection, commissioning of construction in progress, and preservation of superior margins.

Profitability Analysis

The reported annualized DuPont ROE of 14.1% decomposes into a 16.5% net profit margin, 0.693x asset turnover, and 1.24x financial leverage. Profitability, rather than leverage, is the central driver of shareholder returns: the company operates with a predominantly equity-funded balance sheet and D/E of 0.24x. The 16.5% net margin is well above the 10% excellent benchmark, while the 25.0% EBIT margin is also firmly in the excellent range. Gross margin improved to 34.4% from approximately 33.9% in the prior-year period, adding around 50bp. Operating-margin expansion was more modest, at approximately 10bp, because SG&A grew 8.7%, materially faster than 3.2% revenue growth. This negative operating-leverage pattern is the main constraint on incremental margin conversion, although the absolute SG&A burden remains low. The five-factor DuPont view shows a 0.983 interest burden, confirming that financing costs are immaterial to earnings generation. Interest expense was only ¥8m and EBIT interest coverage was 401.39x. The 0.669 tax burden was somewhat below a normal 0.70-plus reference point, reflecting a 33.0% effective tax rate and tempering net-income growth relative to operating profit. Foreign-exchange losses of ¥61m were the key non-operating headwind, causing ordinary-income growth to lag operating-income growth. The ¥1m gain on sale of assets was immaterial, so reported earnings were not meaningfully dependent on extraordinary gains. EBITDA was ¥3.47bn and the EBITDA margin was 27.4%, underscoring strong underlying operating profitability. As a JGAAP reporter, the absence of reported goodwill-related items means EBITDA and EBITDA before goodwill amortization are both ¥3.47bn. The sustainability of returns therefore hinges less on balance-sheet leverage and more on whether the company can convert high accounting margins into cash while scaling its operating asset base.

Growth Assessment

Revenue growth of 3.2% was moderate in Q2 relative to the 10.4% growth embedded in full-year revenue guidance. Gross profit increased 4.8%, faster than sales, indicating favorable gross-profit conversion during the first half. Operating income growth of 3.4% broadly tracked revenue growth despite faster SG&A expansion. Net income growth of 1.8% lagged due to increased foreign-exchange losses and a slightly higher effective tax burden. Q2 progress against full-year guidance was 49.2% for revenue, 58.4% for operating income, 57.3% for ordinary income, and 57.3% for net income. Relative to the standard 50% first-half benchmark, operating, ordinary, and net-income progress are ahead by roughly 7-8 percentage points, whereas revenue is broadly on schedule. This implies that the full-year outlook allows for a lower second-half margin than achieved in Q2, a heavier second-half revenue profile, or both. Full-year implied operating margin is 21.1%, below the Q2 25.0% margin, leaving a meaningful buffer if Q2 profitability is maintained. The ongoing capital program is significant: purchases of non-current assets were ¥1.30bn during Q2, and construction in progress was ¥3.32bn. Capex represented approximately 4.4x depreciation and amortization of ¥0.30bn, signaling expansion rather than maintenance-only spending. This investment can support future growth, but it increases the importance of timely project completion and utilization. Receivables expanded much faster than sales, so reported growth currently requires validation through collections. The company has sufficient internal liquidity to fund expansion without meaningful balance-sheet strain.

Financial Health

Financial health is strong on conventional liquidity and leverage measures. Current assets of ¥27.06bn covered current liabilities of ¥5.47bn by 4.95x, and the quick ratio was 4.52x. Working capital was ¥21.59bn, providing a substantial operating liquidity cushion. Cash and deposits of ¥13.16bn represented 36.1% of total assets and exceeded total interest-bearing debt of ¥1.95bn by ¥11.22bn. Debt-to-equity was a conservative 0.24x, debt/capital was 6.2%, and debt/EBITDA was only 0.56x. Interest coverage of 401.39x and EBITDA interest coverage of 439.24x indicate negligible debt-service pressure. Current liabilities declined to ¥5.47bn from ¥6.36bn a year earlier, while total liabilities declined to ¥6.96bn from ¥7.99bn. Short-term borrowings were ¥0.86bn and the current portion of long-term loans was ¥0.35bn, together representing the reported 44.2% short-term-debt ratio. This creates a refinancing-risk flag because the short-term share exceeds 40%, but the risk is substantially mitigated by cash equal to 15.31x short-term debt and by the very low total debt burden. Accounts receivable increased 46.0% year on year to ¥5.22bn, far outpacing revenue growth. Electronically recorded monetary claims were also ¥5.09bn, bringing customer claim exposure to approximately ¥10.31bn. This concentration in receivable-type assets elevates collection and working-capital-management importance despite the strong current ratio. Investment securities rose 32.6% to ¥0.12bn, but remain immaterial at 0.3% of assets. PPE was ¥9.07bn, or 24.8% of assets, and construction in progress represented 36.6% of PPE. The high construction-in-progress ratio is a material execution risk: delayed completion, cost overruns, or underutilization could defer returns and potentially create impairment exposure. No impairment loss or goodwill-related issue was reported for the period.

Notable B/S Changes

Accounts receivable: +¥1.64bn (+46.0%) to ¥5.22bn - growth materially exceeded the 3.2% increase in revenue and coincided with weak operating cash flow; collection velocity and customer-credit quality require monitoring. Investment securities: +¥0.03bn (+32.6%) to ¥0.12bn - percentage growth was notable but the balance remains immaterial at 0.3% of total assets. Construction in progress: ¥3.32bn, equal to 36.6% of PPE - a large in-progress asset base indicates meaningful expansion investment; completion timing, final cost, and post-completion returns are key execution variables.

Cash Flow Quality

Cash-flow quality is the principal area requiring attention. Operating cash flow was ¥0.36bn, down from ¥1.01bn in the prior-year period, despite net income increasing to ¥2.09bn. Accordingly, OCF/net income was only 0.17x, well below the 0.8x concern threshold, and cash conversion of OCF/EBITDA was only 0.10x versus a 0.7x minimum reference. The root cause was working-capital absorption rather than weak reported profitability. Trade receivables increased by ¥2.19bn during the period, which was the dominant drag on operating cash flow. Inventory increased by ¥0.17bn, adding further cash consumption. These movements are consistent with the high-receivable-days alert of 75 days, above the 60-day threshold. Trade payables increased by ¥0.48bn and partially offset receivable growth, but not enough to prevent weak operating cash conversion. The accruals ratio of 4.7% remains below the 5% high-quality benchmark, which moderates concern that earnings are broadly unsupported by cash; nevertheless, the low OCF/net-income ratio remains a clear near-term quality warning. Investing cash flow was negative ¥1.29bn, primarily reflecting ¥1.30bn of non-current-asset purchases. Free cash flow was therefore negative ¥0.93bn. Financing cash flow was negative ¥0.83bn, including ¥0.67bn of cash dividends paid and long-term debt repayment. Cash decreased ¥1.75bn during the period, but ending cash and cash equivalents remained substantial at ¥12.99bn. The combination of receivable expansion, elevated construction in progress, and negative free cash flow warrants monitoring for evidence that investment and sales growth are translating into durable cash generation.

Dividend Sustainability

No Q2 dividend was paid. Full-year guidance calls for DPS of ¥18.00, equivalent to an indicated dividend payout ratio of approximately 20.8% based on forecast EPS of ¥86.42. This is comfortably below the 60% sustainability benchmark. The indicated cash dividend requirement is approximately ¥0.76bn based on outstanding shares, which appears manageable relative to the company’s cash balance of ¥13.16bn and net cash position. The company also paid ¥0.67bn in cash dividends during the reported period, demonstrating continuing shareholder distributions. However, Q2 free cash flow was negative ¥0.93bn because operating cash flow was weak and capital expenditure was elevated. As a result, current-period dividend funding depends more on accumulated liquidity than on contemporaneous free cash flow. This does not presently threaten sustainability given the conservative capital structure, but sustained weak cash conversion would reduce the quality of dividend coverage. No share repurchases were indicated; therefore, the relevant distribution metric is the dividend payout ratio rather than a total return ratio. The near-term policy outlook appears financially supportable, subject to improved receivable collection and successful conversion of construction-in-progress investments into operating cash flow.

Risk Assessment

Business risks include Working-capital risk is elevated: trade receivables increased 46.0% year on year to ¥5.22bn, while electronic monetary claims were ¥5.09bn and the quality alert indicates DSO of 75 days. Slower customer collections would pressure cash generation and could raise credit-loss exposure., Capital-project execution risk is material because construction in progress of ¥3.32bn equals 36.6% of PPE, above the 20% alert threshold. Delays, budget overruns, delayed ramp-up, or inadequate utilization could postpone returns on capital and increase future impairment risk., Margin risk remains relevant because SG&A increased 8.7%, faster than 3.2% revenue growth. Continued cost growth without an acceleration in sales would narrow the currently high 25.0% operating margin., Foreign-exchange exposure affected Q2 earnings through ¥61m of FX losses, materially reducing the conversion of operating income into ordinary income. Further currency volatility may continue to affect below-the-line earnings..

Financial risks include OCF/net income of 0.17x and OCF/EBITDA of 0.10x are materially below quality thresholds. The immediate impact is negative free cash flow of ¥0.93bn despite strong accounting profitability., The short-term debt ratio of 44.2% exceeds the 40% refinancing-risk alert level. The practical impact is limited by cash/short-term debt of 15.31x, debt/EBITDA of 0.56x, and ample current liquidity, but maturity management should still be monitored., The cash balance decreased by ¥1.75bn during Q2 as operating cash generation, capital expenditure, dividends, and debt repayment combined to reduce liquidity. The remaining cash reserve is ample, but repeated outflows would reduce financial flexibility..

Key concerns include Priority 1: confirm that receivables convert to cash in the second half; this is the most direct determinant of whether earnings quality normalizes., Priority 2: monitor construction-in-progress completion, total project spending, and subsequent depreciation, capacity utilization, and revenue contribution., Priority 3: assess whether full-year revenue growth of 10.4% can be achieved without a further rise in receivable days or additional margin dilution., Priority 4: monitor FX losses, as the Q2 ¥61m loss was the principal reason ordinary-income growth lagged operating-income growth..

Investment Implications

Key takeaways include The company combines excellent operating profitability, including a 25.0% operating margin and 16.5% net margin, with conservative leverage., The reported annualized ROE of 14.1% is good, but it is driven mainly by margins rather than leverage or high asset turnover., Q2 earnings are ahead of a standard first-half progress pace against full-year profit guidance, while sales progress is close to the 50% benchmark., Cash conversion is currently weak because receivables and inventories absorbed cash, making cash collection the central confirmation point for earnings quality., The balance sheet has the capacity to support expansion, dividends, and debt maturities despite negative Q2 free cash flow..

Metrics to watch include Operating cash flow relative to net income and EBITDA, DSO, trade receivable and electronically recorded monetary-claim balances, Construction in progress, capital expenditure, and conversion of projects into productive PPE, SG&A growth relative to revenue growth and operating-margin trajectory, Second-half revenue delivery versus the ¥25.70bn full-year sales forecast, Foreign-exchange gains and losses, Short-term debt maturities and cash/short-term-debt coverage.

Regarding relative positioning, The company is positioned as a high-margin, low-leverage operator with exceptionally strong liquidity and low debt-service risk. Its relative weakness is not solvency but cash conversion: receivable growth and large in-progress capital investment currently suppress free cash flow. Sustained collection discipline and successful capital-project execution would be necessary to align cash returns with its strong reported profitability.